nodes	percent_of_prediction	percent_of_DWPC	metapath
Yohimbine—CYP2D6—Fingolimod—multiple sclerosis	0.0834	0.261	CbGbCtD
Yohimbine—HTR1B—trigeminal nucleus—multiple sclerosis	0.0629	0.154	CbGeAlD
Yohimbine—HTR1D—trigeminal nucleus—multiple sclerosis	0.0609	0.15	CbGeAlD
Yohimbine—CYP3A4—Fingolimod—multiple sclerosis	0.0531	0.166	CbGbCtD
Yohimbine—HTR1D—meninx—multiple sclerosis	0.0404	0.0993	CbGeAlD
Yohimbine—HTR1F—trigeminal nerve—multiple sclerosis	0.0403	0.099	CbGeAlD
Yohimbine—CYP3A4—Methylprednisolone—multiple sclerosis	0.0342	0.107	CbGbCtD
Yohimbine—HTR2A—trigeminal nucleus—multiple sclerosis	0.0303	0.0743	CbGeAlD
Yohimbine—CYP3A4—Triamcinolone—multiple sclerosis	0.0259	0.0811	CbGbCtD
Yohimbine—CYP3A4—Mitoxantrone—multiple sclerosis	0.0249	0.078	CbGbCtD
Yohimbine—CYP3A4—Betamethasone—multiple sclerosis	0.0222	0.0696	CbGbCtD
Yohimbine—CYP3A4—Prednisolone—multiple sclerosis	0.0219	0.0686	CbGbCtD
Yohimbine—CYP3A4—Prednisone—multiple sclerosis	0.0207	0.0648	CbGbCtD
Yohimbine—CYP2D6—Dexamethasone—multiple sclerosis	0.0203	0.0636	CbGbCtD
Yohimbine—HTR1B—trigeminal nerve—multiple sclerosis	0.0165	0.0406	CbGeAlD
Yohimbine—HTR1D—trigeminal nerve—multiple sclerosis	0.016	0.0393	CbGeAlD
Yohimbine—CYP3A4—Dexamethasone—multiple sclerosis	0.0129	0.0405	CbGbCtD
Yohimbine—HTR2A—trigeminal nerve—multiple sclerosis	0.00795	0.0195	CbGeAlD
Yohimbine—HTR2A—pons—multiple sclerosis	0.00559	0.0137	CbGeAlD
Yohimbine—DRD2—nerve—multiple sclerosis	0.0044	0.0108	CbGeAlD
Yohimbine—ADRA2A—peripheral nervous system—multiple sclerosis	0.00438	0.0107	CbGeAlD
Yohimbine—HTR2A—pineal body—multiple sclerosis	0.00399	0.00981	CbGeAlD
Yohimbine—HTR2A—peripheral nervous system—multiple sclerosis	0.00372	0.00914	CbGeAlD
Yohimbine—HTR1F—nervous system—multiple sclerosis	0.00331	0.00813	CbGeAlD
Yohimbine—HTR1F—central nervous system—multiple sclerosis	0.00319	0.00783	CbGeAlD
Yohimbine—HTR2A—nerve—multiple sclerosis	0.0029	0.00712	CbGeAlD
Yohimbine—HTR1B—brainstem—multiple sclerosis	0.00259	0.00636	CbGeAlD
Yohimbine—HTR1F—brain—multiple sclerosis	0.00253	0.00622	CbGeAlD
Yohimbine—HTR1D—brainstem—multiple sclerosis	0.00251	0.00616	CbGeAlD
Yohimbine—HTR2C—brainstem—multiple sclerosis	0.00248	0.0061	CbGeAlD
Yohimbine—SLC6A4—brainstem—multiple sclerosis	0.00235	0.00578	CbGeAlD
Yohimbine—DRD3—nervous system—multiple sclerosis	0.00234	0.00574	CbGeAlD
Yohimbine—DRD3—central nervous system—multiple sclerosis	0.00225	0.00553	CbGeAlD
Yohimbine—HTR1A—brainstem—multiple sclerosis	0.00209	0.00513	CbGeAlD
Yohimbine—DRD2—brainstem—multiple sclerosis	0.00189	0.00464	CbGeAlD
Yohimbine—DRD2—retina—multiple sclerosis	0.00182	0.00447	CbGeAlD
Yohimbine—ADRA1B—nervous system—multiple sclerosis	0.0018	0.00441	CbGeAlD
Yohimbine—DRD3—brain—multiple sclerosis	0.00179	0.00439	CbGeAlD
Yohimbine—ADRA1D—nervous system—multiple sclerosis	0.00176	0.00432	CbGeAlD
Yohimbine—HTR2C—medulla oblongata—multiple sclerosis	0.00173	0.00425	CbGeAlD
Yohimbine—ADRA1B—central nervous system—multiple sclerosis	0.00173	0.00425	CbGeAlD
Yohimbine—ADRA1D—central nervous system—multiple sclerosis	0.00169	0.00415	CbGeAlD
Yohimbine—HTR1B—midbrain—multiple sclerosis	0.00165	0.00405	CbGeAlD
Yohimbine—HTR1B—spinal cord—multiple sclerosis	0.00161	0.00395	CbGeAlD
Yohimbine—HTR1D—midbrain—multiple sclerosis	0.0016	0.00392	CbGeAlD
Yohimbine—HTR2C—midbrain—multiple sclerosis	0.00158	0.00389	CbGeAlD
Yohimbine—HTR2C—spinal cord—multiple sclerosis	0.00154	0.00379	CbGeAlD
Yohimbine—SLC6A4—midbrain—multiple sclerosis	0.0015	0.00368	CbGeAlD
Yohimbine—SLC6A4—spinal cord—multiple sclerosis	0.00146	0.00359	CbGeAlD
Yohimbine—ADRA1B—brain—multiple sclerosis	0.00137	0.00337	CbGeAlD
Yohimbine—HTR1B—nervous system—multiple sclerosis	0.00136	0.00333	CbGeAlD
Yohimbine—ADRA1D—brain—multiple sclerosis	0.00134	0.0033	CbGeAlD
Yohimbine—HTR1A—midbrain—multiple sclerosis	0.00133	0.00327	CbGeAlD
Yohimbine—HTR1D—nervous system—multiple sclerosis	0.00131	0.00323	CbGeAlD
Yohimbine—HTR1B—central nervous system—multiple sclerosis	0.00131	0.00321	CbGeAlD
Yohimbine—HTR2C—nervous system—multiple sclerosis	0.0013	0.00319	CbGeAlD
Yohimbine—HTR1A—spinal cord—multiple sclerosis	0.0013	0.00319	CbGeAlD
Yohimbine—ADRA2C—medulla oblongata—multiple sclerosis	0.00128	0.00314	CbGeAlD
Yohimbine—HTR1D—central nervous system—multiple sclerosis	0.00126	0.00311	CbGeAlD
Yohimbine—HTR2C—central nervous system—multiple sclerosis	0.00125	0.00308	CbGeAlD
Yohimbine—HTR2A—brainstem—multiple sclerosis	0.00125	0.00306	CbGeAlD
Yohimbine—SLC6A4—nervous system—multiple sclerosis	0.00123	0.00303	CbGeAlD
Yohimbine—HTR2B—nervous system—multiple sclerosis	0.00122	0.003	CbGeAlD
Yohimbine—DRD2—midbrain—multiple sclerosis	0.0012	0.00296	CbGeAlD
Yohimbine—HTR2A—retina—multiple sclerosis	0.0012	0.00295	CbGeAlD
Yohimbine—SLC6A4—central nervous system—multiple sclerosis	0.00119	0.00292	CbGeAlD
Yohimbine—HTR2B—central nervous system—multiple sclerosis	0.00118	0.00289	CbGeAlD
Yohimbine—ADRA2C—midbrain—multiple sclerosis	0.00117	0.00287	CbGeAlD
Yohimbine—ADRA2C—spinal cord—multiple sclerosis	0.00114	0.0028	CbGeAlD
Yohimbine—CYP2D6—brainstem—multiple sclerosis	0.00113	0.00279	CbGeAlD
Yohimbine—HTR1A—nervous system—multiple sclerosis	0.0011	0.00269	CbGeAlD
Yohimbine—HTR1A—central nervous system—multiple sclerosis	0.00105	0.00259	CbGeAlD
Yohimbine—HTR1B—brain—multiple sclerosis	0.00104	0.00255	CbGeAlD
Yohimbine—HTR1A—cerebellum—multiple sclerosis	0.00103	0.00253	CbGeAlD
Yohimbine—ADRA2A—medulla oblongata—multiple sclerosis	0.00102	0.00251	CbGeAlD
Yohimbine—HTR1D—brain—multiple sclerosis	0.001	0.00247	CbGeAlD
Yohimbine—HTR2C—brain—multiple sclerosis	0.000994	0.00244	CbGeAlD
Yohimbine—DRD2—nervous system—multiple sclerosis	0.000989	0.00243	CbGeAlD
Yohimbine—ADRA2C—nervous system—multiple sclerosis	0.000962	0.00236	CbGeAlD
Yohimbine—DRD2—central nervous system—multiple sclerosis	0.000953	0.00234	CbGeAlD
Yohimbine—SLC6A4—brain—multiple sclerosis	0.000943	0.00231	CbGeAlD
Yohimbine—HTR2B—brain—multiple sclerosis	0.000934	0.00229	CbGeAlD
Yohimbine—ADRA2A—midbrain—multiple sclerosis	0.000934	0.00229	CbGeAlD
Yohimbine—DRD2—cerebellum—multiple sclerosis	0.000931	0.00229	CbGeAlD
Yohimbine—ADRA2C—central nervous system—multiple sclerosis	0.000926	0.00227	CbGeAlD
Yohimbine—ADRA2A—spinal cord—multiple sclerosis	0.000911	0.00224	CbGeAlD
Yohimbine—ADRA2C—cerebellum—multiple sclerosis	0.000905	0.00222	CbGeAlD
Yohimbine—HTR2A—medulla oblongata—multiple sclerosis	0.000869	0.00213	CbGeAlD
Yohimbine—HTR1A—brain—multiple sclerosis	0.000837	0.00206	CbGeAlD
Yohimbine—HTR2A—midbrain—multiple sclerosis	0.000794	0.00195	CbGeAlD
Yohimbine—HTR2A—spinal cord—multiple sclerosis	0.000775	0.0019	CbGeAlD
Yohimbine—ADRA2A—nervous system—multiple sclerosis	0.000768	0.00188	CbGeAlD
Yohimbine—DRD2—brain—multiple sclerosis	0.000756	0.00186	CbGeAlD
Yohimbine—ADRA2A—central nervous system—multiple sclerosis	0.000739	0.00181	CbGeAlD
Yohimbine—ADRA2C—brain—multiple sclerosis	0.000735	0.00181	CbGeAlD
Yohimbine—ADRA2A—cerebellum—multiple sclerosis	0.000722	0.00177	CbGeAlD
Yohimbine—HTR2A—nervous system—multiple sclerosis	0.000653	0.0016	CbGeAlD
Yohimbine—HTR2A—central nervous system—multiple sclerosis	0.000628	0.00154	CbGeAlD
Yohimbine—HTR2A—cerebellum—multiple sclerosis	0.000614	0.00151	CbGeAlD
Yohimbine—CYP3A4—nervous system—multiple sclerosis	0.000604	0.00148	CbGeAlD
Yohimbine—CYP2D6—nervous system—multiple sclerosis	0.000595	0.00146	CbGeAlD
Yohimbine—ADRA2A—brain—multiple sclerosis	0.000587	0.00144	CbGeAlD
Yohimbine—CYP3A4—central nervous system—multiple sclerosis	0.000582	0.00143	CbGeAlD
Yohimbine—CYP2D6—central nervous system—multiple sclerosis	0.000572	0.00141	CbGeAlD
Yohimbine—CYP2D6—cerebellum—multiple sclerosis	0.000559	0.00137	CbGeAlD
Yohimbine—HTR2A—brain—multiple sclerosis	0.000499	0.00122	CbGeAlD
Yohimbine—CYP2D6—brain—multiple sclerosis	0.000454	0.00112	CbGeAlD
Yohimbine—HTR2C—GPCR downstream signaling—IL2—multiple sclerosis	3.09e-05	0.000113	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—SPP1—multiple sclerosis	3.07e-05	0.000112	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—CCL5—multiple sclerosis	3.04e-05	0.000111	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—RRM1—multiple sclerosis	3.04e-05	0.000111	CbGpPWpGaD
Yohimbine—ADRA2C—Metabolism—APOE—multiple sclerosis	3.03e-05	0.000111	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—POMC—multiple sclerosis	3.02e-05	0.00011	CbGpPWpGaD
Yohimbine—ADRA2A—Hemostasis—TGFB1—multiple sclerosis	3.01e-05	0.00011	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—APOE—multiple sclerosis	3.01e-05	0.00011	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—APOE—multiple sclerosis	3.01e-05	0.00011	CbGpPWpGaD
Yohimbine—ADRA2C—GPCR downstream signaling—IL2—multiple sclerosis	3e-05	0.00011	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling by GPCR—POMC—multiple sclerosis	2.99e-05	0.00011	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—CCR5—multiple sclerosis	2.98e-05	0.000109	CbGpPWpGaD
Yohimbine—DRD2—Signaling by GPCR—TYK2—multiple sclerosis	2.97e-05	0.000109	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—SPP1—multiple sclerosis	2.96e-05	0.000108	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—POMC—multiple sclerosis	2.95e-05	0.000108	CbGpPWpGaD
Yohimbine—ADRA1B—GPCR downstream signaling—IL2—multiple sclerosis	2.95e-05	0.000108	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—CCL2—multiple sclerosis	2.95e-05	0.000108	CbGpPWpGaD
Yohimbine—ADRA2A—Hemostasis—MAPK1—multiple sclerosis	2.95e-05	0.000108	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—SPP1—multiple sclerosis	2.94e-05	0.000108	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—IL2RA—multiple sclerosis	2.94e-05	0.000108	CbGpPWpGaD
Yohimbine—HTR1F—Signaling Pathways—STAT3—multiple sclerosis	2.93e-05	0.000107	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling by GPCR—CCL2—multiple sclerosis	2.93e-05	0.000107	CbGpPWpGaD
Yohimbine—HTR2A—Signaling by GPCR—TYK2—multiple sclerosis	2.92e-05	0.000107	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—CD80—multiple sclerosis	2.92e-05	0.000107	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—CXCL10—multiple sclerosis	2.92e-05	0.000107	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling by GPCR—IL2—multiple sclerosis	2.92e-05	0.000107	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—CCL2—multiple sclerosis	2.89e-05	0.000106	CbGpPWpGaD
Yohimbine—HTR1D—Signaling by GPCR—MAPK1—multiple sclerosis	2.89e-05	0.000106	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—CCR5—multiple sclerosis	2.88e-05	0.000105	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—CCR5—multiple sclerosis	2.86e-05	0.000105	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—SPP1—multiple sclerosis	2.86e-05	0.000105	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—CD86—multiple sclerosis	2.85e-05	0.000104	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—IL2RA—multiple sclerosis	2.84e-05	0.000104	CbGpPWpGaD
Yohimbine—HTR1B—Signaling by GPCR—MAPK1—multiple sclerosis	2.83e-05	0.000104	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—IL2RA—multiple sclerosis	2.82e-05	0.000103	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—SPP1—multiple sclerosis	2.82e-05	0.000103	CbGpPWpGaD
Yohimbine—HTR1A—Signaling by GPCR—IL2—multiple sclerosis	2.82e-05	0.000103	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—CCL5—multiple sclerosis	2.81e-05	0.000103	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—CD86—multiple sclerosis	2.8e-05	0.000103	CbGpPWpGaD
Yohimbine—HTR2C—Signaling by GPCR—IL2—multiple sclerosis	2.8e-05	0.000103	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—CCR5—multiple sclerosis	2.79e-05	0.000102	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—POMC—multiple sclerosis	2.77e-05	0.000102	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—CCL5—multiple sclerosis	2.76e-05	0.000101	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—IL2RA—multiple sclerosis	2.75e-05	0.000101	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—CCR5—multiple sclerosis	2.74e-05	0.0001	CbGpPWpGaD
Yohimbine—HTR1F—Signaling Pathways—MYC—multiple sclerosis	2.73e-05	9.99e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling by GPCR—IL2—multiple sclerosis	2.72e-05	9.98e-05	CbGpPWpGaD
Yohimbine—DRD2—GPCR downstream signaling—IL2—multiple sclerosis	2.72e-05	9.97e-05	CbGpPWpGaD
Yohimbine—HTR1F—Signaling Pathways—TGFB1—multiple sclerosis	2.72e-05	9.96e-05	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—CD80—multiple sclerosis	2.72e-05	9.95e-05	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—CD80—multiple sclerosis	2.72e-05	9.95e-05	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—CCL2—multiple sclerosis	2.71e-05	9.94e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—APOE—multiple sclerosis	2.71e-05	9.94e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—IL2RA—multiple sclerosis	2.7e-05	9.9e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling by GPCR—IL2—multiple sclerosis	2.68e-05	9.82e-05	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—TYK2—multiple sclerosis	2.68e-05	9.81e-05	CbGpPWpGaD
Yohimbine—HTR2A—GPCR downstream signaling—IL2—multiple sclerosis	2.68e-05	9.81e-05	CbGpPWpGaD
Yohimbine—HTR1F—Signaling Pathways—MAPK1—multiple sclerosis	2.67e-05	9.77e-05	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—BCHE—multiple sclerosis	2.67e-05	9.77e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling by GPCR—TYK2—multiple sclerosis	2.66e-05	9.74e-05	CbGpPWpGaD
Yohimbine—HTR2B—Signaling by GPCR—MAPK1—multiple sclerosis	2.66e-05	9.73e-05	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—TYK2—multiple sclerosis	2.62e-05	9.61e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—APOE—multiple sclerosis	2.62e-05	9.59e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—APOE—multiple sclerosis	2.61e-05	9.54e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Metabolism—POMC—multiple sclerosis	2.6e-05	9.54e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—SPP1—multiple sclerosis	2.6e-05	9.52e-05	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—POMC—multiple sclerosis	2.58e-05	9.45e-05	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—POMC—multiple sclerosis	2.58e-05	9.45e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—SPP1—multiple sclerosis	2.56e-05	9.36e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—CD86—multiple sclerosis	2.55e-05	9.34e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—APOE—multiple sclerosis	2.53e-05	9.28e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—CCR5—multiple sclerosis	2.53e-05	9.26e-05	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—CCL2—multiple sclerosis	2.53e-05	9.25e-05	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—CCL2—multiple sclerosis	2.53e-05	9.25e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—CCL5—multiple sclerosis	2.51e-05	9.2e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—APOE—multiple sclerosis	2.49e-05	9.13e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—IL2RA—multiple sclerosis	2.49e-05	9.12e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—CCR5—multiple sclerosis	2.49e-05	9.11e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling by GPCR—IL2—multiple sclerosis	2.47e-05	9.05e-05	CbGpPWpGaD
Yohimbine—DRD3—Signaling by GPCR—MAPK1—multiple sclerosis	2.47e-05	9.05e-05	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling by GPCR—MAPK1—multiple sclerosis	2.47e-05	9.05e-05	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—TYK2—multiple sclerosis	2.47e-05	9.03e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Metabolism—APOE—multiple sclerosis	2.46e-05	9.02e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—CD80—multiple sclerosis	2.45e-05	8.98e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—IL2RA—multiple sclerosis	2.45e-05	8.98e-05	CbGpPWpGaD
Yohimbine—ADRA2A—GPCR downstream signaling—IL2—multiple sclerosis	2.44e-05	8.92e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling by GPCR—IL2—multiple sclerosis	2.43e-05	8.91e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Metabolism—ALB—multiple sclerosis	2.37e-05	8.69e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—CD80—multiple sclerosis	2.37e-05	8.67e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—CD80—multiple sclerosis	2.36e-05	8.63e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—POMC—multiple sclerosis	2.33e-05	8.54e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—SPP1—multiple sclerosis	2.33e-05	8.52e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—APOE—multiple sclerosis	2.3e-05	8.42e-05	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—TYK2—multiple sclerosis	2.29e-05	8.4e-05	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—TYK2—multiple sclerosis	2.29e-05	8.4e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—CD80—multiple sclerosis	2.29e-05	8.39e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—CCL2—multiple sclerosis	2.28e-05	8.35e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—CCR5—multiple sclerosis	2.26e-05	8.29e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—APOE—multiple sclerosis	2.26e-05	8.29e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—CD80—multiple sclerosis	2.26e-05	8.26e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—POMC—multiple sclerosis	2.25e-05	8.24e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—POMC—multiple sclerosis	2.24e-05	8.2e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling by GPCR—MAPK1—multiple sclerosis	2.23e-05	8.17e-05	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—IL2—multiple sclerosis	2.23e-05	8.17e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—IL2RA—multiple sclerosis	2.23e-05	8.17e-05	CbGpPWpGaD
Yohimbine—HTR1D—Signaling by GPCR—IL6—multiple sclerosis	2.22e-05	8.13e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling by GPCR—IL2—multiple sclerosis	2.21e-05	8.1e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—CCL2—multiple sclerosis	2.2e-05	8.06e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—CCL2—multiple sclerosis	2.19e-05	8.02e-05	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—IL2—multiple sclerosis	2.18e-05	8e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—POMC—multiple sclerosis	2.18e-05	7.97e-05	CbGpPWpGaD
Yohimbine—HTR1B—Signaling by GPCR—IL6—multiple sclerosis	2.17e-05	7.96e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling by GPCR—MAPK1—multiple sclerosis	2.15e-05	7.89e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling by GPCR—MAPK1—multiple sclerosis	2.14e-05	7.85e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—POMC—multiple sclerosis	2.14e-05	7.85e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—CCL2—multiple sclerosis	2.13e-05	7.8e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Metabolism—POMC—multiple sclerosis	2.12e-05	7.75e-05	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—MMP9—multiple sclerosis	2.11e-05	7.73e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—CCL2—multiple sclerosis	2.1e-05	7.68e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling by GPCR—MAPK1—multiple sclerosis	2.08e-05	7.63e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—CD80—multiple sclerosis	2.08e-05	7.61e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—TYK2—multiple sclerosis	2.07e-05	7.58e-05	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—MMP9—multiple sclerosis	2.07e-05	7.57e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—APOE—multiple sclerosis	2.06e-05	7.54e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling by GPCR—MAPK1—multiple sclerosis	2.05e-05	7.51e-05	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—IL2—multiple sclerosis	2.05e-05	7.51e-05	CbGpPWpGaD
Yohimbine—HTR1F—Signaling Pathways—IL6—multiple sclerosis	2.05e-05	7.51e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—CD80—multiple sclerosis	2.05e-05	7.49e-05	CbGpPWpGaD
Yohimbine—HTR2B—Signaling by GPCR—IL6—multiple sclerosis	2.04e-05	7.47e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—TYK2—multiple sclerosis	2e-05	7.32e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—TYK2—multiple sclerosis	1.99e-05	7.28e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—POMC—multiple sclerosis	1.98e-05	7.23e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—POMC—multiple sclerosis	1.94e-05	7.12e-05	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—MMP9—multiple sclerosis	1.94e-05	7.11e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—TYK2—multiple sclerosis	1.93e-05	7.08e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—CCL2—multiple sclerosis	1.93e-05	7.08e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Metabolism—ALB—multiple sclerosis	1.93e-05	7.06e-05	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—IL2—multiple sclerosis	1.91e-05	6.99e-05	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—IL2—multiple sclerosis	1.91e-05	6.99e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—TYK2—multiple sclerosis	1.9e-05	6.97e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—CCL2—multiple sclerosis	1.9e-05	6.97e-05	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling by GPCR—IL6—multiple sclerosis	1.9e-05	6.95e-05	CbGpPWpGaD
Yohimbine—DRD3—Signaling by GPCR—IL6—multiple sclerosis	1.9e-05	6.95e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling by GPCR—MAPK1—multiple sclerosis	1.89e-05	6.93e-05	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—STAT3—multiple sclerosis	1.88e-05	6.87e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—CD80—multiple sclerosis	1.86e-05	6.82e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling by GPCR—MAPK1—multiple sclerosis	1.86e-05	6.81e-05	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—STAT3—multiple sclerosis	1.84e-05	6.73e-05	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—MMP9—multiple sclerosis	1.81e-05	6.62e-05	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—MMP9—multiple sclerosis	1.81e-05	6.62e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—POMC—multiple sclerosis	1.77e-05	6.48e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—TYK2—multiple sclerosis	1.76e-05	6.43e-05	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—MYC—multiple sclerosis	1.74e-05	6.39e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—BCHE—multiple sclerosis	1.74e-05	6.38e-05	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—TGFB1—multiple sclerosis	1.74e-05	6.37e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—CCL2—multiple sclerosis	1.73e-05	6.34e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—TYK2—multiple sclerosis	1.73e-05	6.32e-05	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—STAT3—multiple sclerosis	1.73e-05	6.32e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—IL2—multiple sclerosis	1.72e-05	6.31e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling by GPCR—IL6—multiple sclerosis	1.71e-05	6.28e-05	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—MYC—multiple sclerosis	1.71e-05	6.25e-05	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—MAPK1—multiple sclerosis	1.71e-05	6.25e-05	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—TGFB1—multiple sclerosis	1.7e-05	6.24e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling by GPCR—MAPK1—multiple sclerosis	1.69e-05	6.2e-05	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—MAPK1—multiple sclerosis	1.67e-05	6.12e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—IL2—multiple sclerosis	1.66e-05	6.09e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling by GPCR—IL6—multiple sclerosis	1.66e-05	6.06e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—IL2—multiple sclerosis	1.65e-05	6.06e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling by GPCR—IL6—multiple sclerosis	1.65e-05	6.03e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—MMP9—multiple sclerosis	1.63e-05	5.97e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—IL2—multiple sclerosis	1.61e-05	5.89e-05	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—STAT3—multiple sclerosis	1.61e-05	5.88e-05	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—STAT3—multiple sclerosis	1.61e-05	5.88e-05	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—APOE—multiple sclerosis	1.6e-05	5.87e-05	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—MYC—multiple sclerosis	1.6e-05	5.87e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling by GPCR—IL6—multiple sclerosis	1.6e-05	5.87e-05	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—TGFB1—multiple sclerosis	1.6e-05	5.86e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—IL2—multiple sclerosis	1.58e-05	5.8e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling by GPCR—IL6—multiple sclerosis	1.58e-05	5.77e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—MMP9—multiple sclerosis	1.57e-05	5.77e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—TYK2—multiple sclerosis	1.57e-05	5.75e-05	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—MAPK1—multiple sclerosis	1.57e-05	5.75e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—MMP9—multiple sclerosis	1.57e-05	5.74e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—MMP9—multiple sclerosis	1.52e-05	5.58e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—MMP9—multiple sclerosis	1.5e-05	5.49e-05	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—MYC—multiple sclerosis	1.49e-05	5.47e-05	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—MYC—multiple sclerosis	1.49e-05	5.47e-05	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—TGFB1—multiple sclerosis	1.49e-05	5.45e-05	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—TGFB1—multiple sclerosis	1.49e-05	5.45e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—IL2—multiple sclerosis	1.46e-05	5.35e-05	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—MAPK1—multiple sclerosis	1.46e-05	5.35e-05	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—MAPK1—multiple sclerosis	1.46e-05	5.35e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling by GPCR—IL6—multiple sclerosis	1.45e-05	5.32e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—STAT3—multiple sclerosis	1.45e-05	5.31e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—IL2—multiple sclerosis	1.44e-05	5.26e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling by GPCR—IL6—multiple sclerosis	1.43e-05	5.24e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—STAT3—multiple sclerosis	1.4e-05	5.13e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—STAT3—multiple sclerosis	1.39e-05	5.1e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—MMP9—multiple sclerosis	1.38e-05	5.06e-05	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—POMC—multiple sclerosis	1.38e-05	5.05e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—MMP9—multiple sclerosis	1.36e-05	4.98e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—STAT3—multiple sclerosis	1.35e-05	4.96e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—MYC—multiple sclerosis	1.35e-05	4.93e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—TGFB1—multiple sclerosis	1.34e-05	4.92e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—STAT3—multiple sclerosis	1.33e-05	4.88e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—MAPK1—multiple sclerosis	1.32e-05	4.83e-05	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—IL6—multiple sclerosis	1.31e-05	4.8e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—IL2—multiple sclerosis	1.31e-05	4.79e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling by GPCR—IL6—multiple sclerosis	1.3e-05	4.76e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—MYC—multiple sclerosis	1.3e-05	4.76e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—TGFB1—multiple sclerosis	1.3e-05	4.75e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—MYC—multiple sclerosis	1.29e-05	4.74e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—TGFB1—multiple sclerosis	1.29e-05	4.73e-05	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—IL6—multiple sclerosis	1.28e-05	4.7e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—MAPK1—multiple sclerosis	1.27e-05	4.66e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—MAPK1—multiple sclerosis	1.27e-05	4.64e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—MYC—multiple sclerosis	1.26e-05	4.61e-05	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—ALB—multiple sclerosis	1.26e-05	4.6e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—TGFB1—multiple sclerosis	1.26e-05	4.6e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—MYC—multiple sclerosis	1.24e-05	4.54e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—MMP9—multiple sclerosis	1.24e-05	4.53e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—TGFB1—multiple sclerosis	1.24e-05	4.53e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—MAPK1—multiple sclerosis	1.23e-05	4.51e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—STAT3—multiple sclerosis	1.23e-05	4.5e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—MAPK1—multiple sclerosis	1.21e-05	4.44e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—STAT3—multiple sclerosis	1.21e-05	4.43e-05	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—IL6—multiple sclerosis	1.21e-05	4.42e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—MYC—multiple sclerosis	1.14e-05	4.18e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—TGFB1—multiple sclerosis	1.14e-05	4.17e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—MYC—multiple sclerosis	1.12e-05	4.11e-05	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—IL6—multiple sclerosis	1.12e-05	4.11e-05	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—IL6—multiple sclerosis	1.12e-05	4.11e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—TGFB1—multiple sclerosis	1.12e-05	4.1e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—MAPK1—multiple sclerosis	1.12e-05	4.09e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—STAT3—multiple sclerosis	1.1e-05	4.03e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—MAPK1—multiple sclerosis	1.1e-05	4.03e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—APOE—multiple sclerosis	1.05e-05	3.84e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—MYC—multiple sclerosis	1.02e-05	3.74e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—TGFB1—multiple sclerosis	1.02e-05	3.73e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—IL6—multiple sclerosis	1.01e-05	3.71e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—MAPK1—multiple sclerosis	1e-05	3.66e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—IL6—multiple sclerosis	9.78e-06	3.58e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—IL6—multiple sclerosis	9.73e-06	3.56e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—IL6—multiple sclerosis	9.46e-06	3.46e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—IL6—multiple sclerosis	9.31e-06	3.41e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—POMC—multiple sclerosis	9.01e-06	3.3e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—IL6—multiple sclerosis	8.59e-06	3.14e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—IL6—multiple sclerosis	8.45e-06	3.09e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—ALB—multiple sclerosis	8.22e-06	3.01e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—IL6—multiple sclerosis	7.69e-06	2.81e-05	CbGpPWpGaD
